GlobeNewswire Inc.··Bcc ResearchAI-Powered Lung Cancer Revolution: $3B in Funding Reshapes Drug Discovery
AI technologies achieving 85-95% accuracy in biomarker identification are reshaping lung cancer drug discovery, with $3B in recent funding backing innovation by major pharma firms.
BMYCELGrMRKPFESNY+1artificial intelligencepersonalized medicine